Pulse.

a daily field guide to health research that matters

◆ Console

‹ Thu · 12 Nov 2026
Standard addition

Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience.

A modified stem cell transplant regimen for brain lymphoma caused less severe mouth damage than standard treatment while controlling disease similarly.

This retrospective single-center comparative cohort study examined Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience. BuTT conditioning showed similar early disease control to TBC with less grade 3-4 mucositis and no non-relapse deaths in this small, nonrandomized cohort.

What the study was

Study design
Retrospective single-center comparative cohort study
Sample size
18
Category
Treatment Innovation
Maturity
Exploratory
Journal
Transplantation and cellular therapy

Why it surfaced

Retained after review of PubMed metadata and abstract because its retrospective single-center comparative cohort study directly informs hematologic malignancies; scoring was capped conservatively for design and evidence maturity.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.